What does Synthetic Design Lab do?
Synthetic Design Lab is a San Francisco-based biotechnology company specializing in antibody-drug conjugates (ADCs). It is advancing its novel SYNTHBODY therapeutic platform to improve targeted payload delivery against a range of cancer indications.
How much did they raise?
The company raised $20M in funding, with the round led by Playground Global and Godfrey Capital. The funding round did not specify a series, highlighting the company's focus on rapid advancement rather than series categorization.
What are their plans for the money?
Synthetic Design Lab plans to use the funds to advance its first therapeutic candidate into clinical trials next year, potentially accelerating the development of more effective and safer targeted cancer therapies.
What have they achieved so far?
The company has already demonstrated progress with its SYNTHBODY platform, engineered to optimize targeted delivery in ADCs, and is led by industry pioneers with substantial experience in cancer immunotherapy and antibody engineering.
